Is Rti Surgical Inc (NASDAQ:RTIX)’s Fuel Running Low? Reports Show More Sellers

July 11, 2018 - By Louis Casey

Investors sentiment decreased to 1.15 in Q1 2018. Its down 0.20, from 1.35 in 2017Q4. It dropped, as 8 investors sold RTI Surgical, Inc. shares while 33 reduced holdings. 16 funds opened positions while 31 raised stakes. 42.21 million shares or 0.26% more from 42.10 million shares in 2017Q4 were reported.
Price T Rowe Associate Inc Md invested in 0% or 85,367 shares. Rhumbline Advisers accumulated 50,111 shares. Rock Springs Management Lp, Maryland-based fund reported 1.95 million shares. Citadel Advsrs Ltd Liability Corporation owns 28,142 shares or 0% of their US portfolio. Wedge Mngmt L Limited Partnership Nc has 324,500 shares. Millrace Asset Grp Inc holds 129,920 shares. Schwab Charles Invest Management Incorporated has 108,300 shares. Blackrock reported 4.68M shares stake. Macquarie Gp has 85,064 shares. Sg Americas Securities Limited owns 0% invested in RTI Surgical, Inc. (NASDAQ:RTIX) for 34,076 shares. Tci Wealth Incorporated invested 0% of its portfolio in RTI Surgical, Inc. (NASDAQ:RTIX). Hillman reported 2.02% stake. Credit Suisse Ag owns 30,938 shares for 0% of their portfolio. Jacobs Levy Equity Inc owns 141,766 shares. Hightower Ltd Company holds 12,000 shares or 0% of its portfolio.

The stock of Rti Surgical Inc (NASDAQ:RTIX) registered an increase of 0.14% in short interest. RTIX’s total short interest was 918,400 shares in July as published by FINRA. Its up 0.14% from 917,100 shares, reported previously. With 75,900 shares average volume, it will take short sellers 12 days to cover their RTIX’s short positions. The short interest to Rti Surgical Inc’s float is 2.19%.

The stock decreased 4.08% or $0.2 during the last trading session, reaching $4.7. About 130,028 shares traded or 10.04% up from the average. RTI Surgical, Inc. (NASDAQ:RTIX) has declined 10.78% since July 11, 2017 and is downtrending. It has underperformed by 23.35% the S&P500.

RTI Surgical, Inc., together with its subsidiaries, designs, develops, makes, and distributes orthopedic and other surgical implants for use in various surgical procedures worldwide. The company has market cap of $298.11 million. The firm provides natural tissue implants, as well as metal and synthetic implants for the treatment of spinal and other orthopedic disorders. It has a 83.93 P/E ratio. It processes donated human musculoskeletal and other tissues, including bone, cartilage, tendons, ligaments, fascia lata, pericardium, sclera, cornea, and dermal tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

More news for RTI Surgical, Inc. (NASDAQ:RTIX) were recently published by: Seekingalpha.com, which released: “RTI Surgical commercially launches Fortilink-TS and -L IBF systems with TETRAfuse 3D technology” on June 12, 2018. Prnewswire.com‘s article titled: “Zavation Medical Products Announces Brian K. Hutchison as Newest Member of its Board of Directors” and published on June 20, 2018 is yet another important article.

RTI Surgical, Inc. (NASDAQ:RTIX) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>